Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion-Reference-Cited by-同舟云学术

Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion

Published:2022-05 Issue:5 Volume:24 Page:456-472
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Srinivasan Akshaya^ORCID,Sathiyanathan Padmapriya^ORCID,Yin Lu^ORCID,Liu Tong Ming^ORCID,Lam Alan,Ravikumar Maanasa^ORCID,Smith Raymond Alexander Alfred^ORCID,Loh Han Ping^ORCID,Zhang Ying,Ling Ling,Ng Say Kong^ORCID,Yang Yuan Sheng,Lezhava Alexander,Hui James,Oh Steve,Cool Simon M.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference231 articles.

1. Mesenchymal stem cells avoid allogeneic rejection;Ryan;Journal of Inflammation,2005

2. Mesenchymal stem cells: immune evasive, not immune privileged;Ankrum;Nat Biotechnol,2014

3. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli;Di Nicola;Blood,2002

4. Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application;Wang;Stem Cells Int,2018

5. MSCs: The Sentinel and Safe-Guards of Injury;Caplan;Journal of Cellular Physiology,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An examination of process models and model risk frameworks for pharmaceutical manufacturing;International Journal of Pharmaceutics: X;2024-12

2. Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway;International Journal of Molecular Sciences;2024-09-04

3. Bone marrow-derived mesenchymal stem cells reduce CCl ₄ -induced kidney injury and fibrosis in male Wistar rats;Renal Failure;2024-07-25

4. Single-Cell RNA Sequencing Identifies WARS1+ Mesenchymal Stem Cells with Enhanced Immunomodulatory Capacity and Improved Therapeutic Efficacy;The Journal of Immunology;2024-06-10

5. Therapeutic potential and impact of nanoengineered patient‐derived mesenchymal stem cells in a murine resection and recurrence model of human glioblastoma;Bioengineering & Translational Medicine;2024-05-07